Pharmaceuticals

7.9k papers and 100.8k indexed citations i.

About

The 7.9k papers published in Pharmaceuticals in the last decades have received a total of 100.8k indexed citations. Papers published in Pharmaceuticals usually cover Molecular Biology (2.8k papers), Pharmacology (897 papers) and Oncology (893 papers) specifically the topics of Computational Drug Discovery Methods (368 papers), Synthesis and biological activity (352 papers) and Essential Oils and Antimicrobial Activity (256 papers). The most active scholars publishing in Pharmaceuticals are Guangshun Wang, Ali Adem Bahar, Dacheng Ren, Filomena Nazzaro, Florinda Fratianni, Raffaele Coppola, Vincenzo De Feo, Paul Hyman, Ute Hennrich and Laura De Martino.

In The Last Decade

Fields of papers published in Pharmaceuticals

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Pharmaceuticals. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Pharmaceuticals

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Pharmaceuticals. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Pharmaceuticals with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025